AstraZeneca, Merck score win with Lynparza approval for pancreatic cancer December 30, 2019 The drug is now the only approved medicine in biomarker-selected patients with advanced pancreatic cancer. from Moneycontrol Business News https://ift.tt/35awRrv Share Get link Facebook X Pinterest Email Other Apps Labels Business Moneycontrol Business News Share Get link Facebook X Pinterest Email Other Apps Comments
The drug is now the only approved medicine in biomarker-selected patients with advanced pancreatic cancer.
Comments
Post a Comment